Please select the option that best describes you:

How long would you anticoagulate a patient with recurrent VTE who has ongoing risk factors for intracranial bleeding?  

What would be your preferred anticoagulation agent?

Has a history of intracranial hemorrhages in the absence of anticoagulation due to abnormal anatomy (cavernous hemangiomas), although no recent bleeding. Initial VTE was an unprovoked subsegmental PE found 3 months prior that was not treated due to bleeding risk. Now with a provoked large saddle PE after major lung surgery, with a clot remaining despite thrombectomy.



Answer from: at Academic Institution
Comments
Medical Oncologist at Medical University of South Carolina
Yes, the patient’s preferences are key. Howe...
at University of Rochester School of Medicine and Dentistry
Dr. @Djulbegovic - thank you so much for bringing ...
Medical Oncologist at Virginia Cancer Spclsts PC
Not sure if there is data or even if it makes sens...
Sign In or Register to read more